Jim Simons Celularity Inc Transaction History

Renaissance Technologies LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 13, 2024	BUY	$0.17 - $0.33 $51,012 - $99,024	300,074 Added 55.22%	843,474 $209,000
Q3 2023 Nov 14, 2023	BUY	$0.22 - $0.56 $59,178 - $150,636	268,994 Added 98.03%	543,400 $121,000
Q2 2023 Aug 11, 2023	BUY	$0.42 - $0.81 $81,566 - $157,306	194,206 Added 242.15%	274,406 $146,000
Q1 2023 May 12, 2023	BUY	$0.56 - $1.15 $31,582 - $64,857	56,398 Added 236.95%	80,200 $50,000
Q4 2022 Feb 13, 2023	BUY	$1.08 - $2.35 $25,706 - $55,934	23,802 New	23,802 $31,000

23.6M

Ticker CELU
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 142,424,000
Market Cap $319M
Description
Celularity Inc., a clinical-stage biotechnology company, develops off-the-shelf placental-derived allogeneic cell therapies for the treatment of cancer, immune, and infectious diseases. It operates through three segments: Cell Therapy, Degenerative Disease, and BioBanking. The company's lead therapeutic programs include CYCART-19, a placental-de...

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.